TY - JOUR T1 - Correction: 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2019-000845corr1 VL - 8 IS - 1 SP - e000845corr1 A2 - , Y1 - 2020/06/01 UR - http://jitc.bmj.com/content/8/1/e000845corr1.abstract ER -